Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

X

Manasi Vaidya

09 Jun 2021

Comment

Trial that pits Covid-19 monoclonal antibodies to weigh efficacy signals recruits 1,500 participants, with an interim analysis expected shortly

09 Jun 2021

02 Jun 2021

Comment

UK observational Covid-19 long-hauler study including paediatrics to tap into immunological data; launch in the next couple of months, source says

02 Jun 2021

01 Mar 2021

Comment

AbbVie’s plan to push Rinvoq to counter Humira biosimilar surge dampens after questions on JAK inhibitor class safety, biosimilar uptake still a challenge

01 Mar 2021

19 Feb 2021

Comment

AbbVie’s successful hard-ball with Humira legal strategy unlikely to spawn similar efforts; potential appeals outcome unclear

19 Feb 2021

12 Feb 2021

Comment

New SARS-CoV-2 variants push Covid-19 vaccine long-term durability questions to back seat

12 Feb 2021

11 Feb 2021

Comment

Orbsen closes Covid-19 study of its mesenchymal stromal cell product, expects results in late March

11 Feb 2021

27 Jan 2021

Comment

Travere’s sparsentan approvable but experts divided on its first-line use in focal segmental glomerulosclerosis

27 Jan 2021

27 Jan 2021

Comment

Market traction for ImmunoGen’s Phase III mirvetuximab in targeted ovarian cancer niche hinges on practical diagnostic but long-term success supported by experts

27 Jan 2021

15 Jan 2021

Comment

AzurRx engages CROs Rho and Linical in separate Phase II trials in cystic fibrosis with pancreatic insufficiency

15 Jan 2021

25 Dec 2020

Comment

GlaxoSmithKline/Vir Biotechnology’s and AstraZeneca’ mAbs eyed in early COVID-19

25 Dec 2020